RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter.
- Published in:
- Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 6, p. 1, doi. 10.1111/jcmm.18115
- By:
- Publication type:
- Article
Works by Feng, Qinmei
Results: 4
1
2
Lactate activates CCL18 expression via H3K18 lactylation in macrophages to promote tumorigenesis of ovarian cancer.
- Published in:
- Acta Biochimica et Biophysica Sinica, 2024, v. 56, n. 9, p. 1373, doi. 10.3724/abbs.2024111
- By:
- Publication type:
- Article
3
Analysis of prognostic value of lactate metabolism-related genes in ovarian cancer based on bioinformatics.
- Published in:
- Journal of Ovarian Research, 2024, v. 17, n. 1, p. 1, doi. 10.1186/s13048-024-01426-z
- By:
- Publication type:
- Article
4
1-MT inhibits the invasion of CBP-resistant ovarian cancer cells via down-regulating IDO expression and re-activating immune cells function.
- Published in:
- BMC Pharmacology & Toxicology, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s40360-020-00439-w
- By:
- Publication type:
- Article